Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
Visa to Move European Headquarters to London’s Canary Wharf 
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens 
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
Merck, a leading science and technology company that operates across life science, healthcare and electronics, has bought the chemical business of Mecaro Co. Ltd., a Korean company specializing in materials and components for semiconductors.
Merck acquired Mecaro in an effort to boost its line-up of materials used for the production of semiconductor products. The German firm further explained on Wednesday, Aug. 17, that the deal is part of the company’s electronics business unit’s “Level Up” growth program.
The agreement also includes investments of more than €3 billion or around $3.05 billion from 2021 to 2025 for innovation and capacities, where the focus will be four key priorities which are: scale, technology, portfolio, and capabilities.
At any rate, according to The Korea Times, the acquisition deal between Merck and Mecaro is worth €110 million. The pay scheme involves an upfront cash payment of €75 million and contingent milestone payments of up to €35 million.
The deal is expected to be completed and closed within the fourth quarter of this year. But then again, just like any other acquisition transaction, this is still subject to regulatory clearance and other customary closing conditions.
Under the agreement, Merck will be securing the production plant of Mecaro located in Eumseong, North Chungcheong Province, as well as its research and development (R&D) facility in Daejeon. It learned that Mecaro has about 100 dedicated staff and mainly produces precursors that are used in Thin Film deposition.
“In acquiring this portion of Mecaro’s business, we will continue to expand a key segment of our Semiconductor Solutions portfolio,” Merck’s chief executive officer of electronics and board member, Kai Beckmann, said in a press release.
He added, “Simultaneously, we are building on our localization efforts and gaining a state-of-the-art production facility in Eumseong and an R&D lab in Daejeon, both supporting our capacity expansion plans and these turnkey spaces will be one of the crucial elements in executing our Level Up investments in Korea.”
Mecaro’s president and CEO, Jae Jung Lee, further said it is looking forward to the partnership.
